In AD, increased P231 tau levels in the CSF predict lower hippocampal volumes and greater declines in volume over time (Hampel et al., 2005), and P231 tau levels predict cognitive decline in individuals with mild cognitive impairment (Buerger et al., 2002). Here, MAPT is linked to Alzheimer disease.